3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Lung Neoplasms
102
Carcinoma, Non-Small-Cell Lung
84
Breast Neoplasms
16
Neoplasm Metastasis
14
Melanoma
14
Brain Neoplasms
14
Small Cell Lung Carcinoma
13
Esophageal Neoplasms
10
Colorectal Neoplasms
9
Carcinoma, Renal Cell
9
Pancreatic Neoplasms
8
Ovarian Neoplasms
8
Adenocarcinoma of Lung
8
Prostatic Neoplasms
7
Carcinoma, Hepatocellular
7
Colonic Neoplasms
6
Stomach Neoplasms
5
Carcinoma, Transitional Cell
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Thyroid Neoplasms
4
Sarcoma, Kaposi
4
Rectal Neoplasms
4
Meningeal Carcinomatosis
4
Squamous Cell Carcinoma of Head and Neck
3
Neoplasms
3
Lymphoma
3
Head and Neck Neoplasms
3
HIV Infections
3
Carcinoma, Medullary
3
Interventions
Cisplatin
57
Pemetrexed
46
pembrolizumab
18
Nivolumab
15
Carboplatin
15
Gemcitabine
14
Cyclophosphamide
13
Radiotherapy
10
Drug Therapy
9
atezolizumab
8
Platinum
7
Ipilimumab
7
Doxorubicin
7
durvalumab
6
1,2-diaminocyclohexaneplatinum II citrate
6
tremelimumab
5
sodium thiosulfate
5
Vinorelbine
5
Radiotherapy, Intensity-Modulated
5
Interleukin-2
5
Chemotherapy, Adjuvant
5
Cerebral Decortication
5
sargramostim
4
fludarabine
4
defactinib
4
aldesleukin
4
tumor necrosis factor-alpha, CNGRC fusion protein, human
3
cediranib
3
Photochemotherapy
3
Neoadjuvant Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Magnetic Resonance Spectroscopy
×
Thoracic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled